Aurinia Pharmaceuticals Inc.

NasdaqGM:AUPH Stock Report

Market Cap: US$736.1m

Aurinia Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:AUPH Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Mar 24SellUS$99,551Scott HabigIndividual17,777US$5.60
06 Mar 24SellUS$194,942Joseph MillerIndividual34,811US$5.60
06 Mar 24SellUS$711,094Peter GreenleafIndividual126,981US$5.60
06 Mar 24SellUS$323,372Stephen RobertsonIndividual57,745US$5.60
06 Mar 24SellUS$224,064Matthew DonleyIndividual40,665US$5.51
27 Feb 24SellUS$30,073Volker KnappertzIndividual4,930US$6.10
20 Feb 24SellUS$137,800Volker KnappertzIndividual25,146US$5.48
20 Feb 24SellUS$86,951Scott HabigIndividual15,867US$5.48
23 May 23SellUS$52,359Daniel BillenIndividual4,650US$11.26
23 May 23SellUS$54,217Jill LeversageIndividual4,815US$11.26
23 May 23SellUS$54,251R. Mackay-DunnIndividual4,818US$11.26
22 May 23SellUS$54,205R. Mackay-DunnIndividual4,818US$11.25

Insider Trading Volume

Insider Buying: AUPH insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of AUPH?
Owner TypeNumber of SharesOwnership Percentage
Private Companies22,5170.0156%
Public Companies1,123,6080.777%
Individual Insiders2,192,5381.52%
Hedge Funds9,536,0006.59%
Institutions50,664,95435%
General Public81,078,14556.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 35.98% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.59%
Armistice Capital LLC
9,536,000US$48.5m57.7%1.28%
6.17%
BlackRock, Inc.
8,921,049US$45.4m6.05%no data
4.42%
ILJIN SNT Co., Ltd
6,396,283US$32.6m5.54%no data
2.75%
New Enterprise Associates, Inc.
3,969,834US$20.2m0%1.09%
1.87%
State Street Global Advisors, Inc.
2,704,382US$13.8m4.03%no data
1.62%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
2,346,584US$11.9m-0.16%no data
1.33%
Goldman Sachs Asset Management, L.P.
1,925,963US$9.8m40%no data
1.09%
Geode Capital Management, LLC
1,569,136US$8.0m5.47%no data
1.04%
The Vanguard Group, Inc.
1,510,498US$7.7m1.77%no data
0.98%
Citigroup Inc.,Banking and Securities Investments
1,416,834US$7.2m60.3%0.01%
0.94%
Morgan Stanley, Investment Banking and Brokerage Investments
1,365,648US$7.0m2.97%no data
0.78%
Lotte Chemical Corporation
1,123,608US$5.7m0%no data
0.74%
Northern Trust Global Investments
1,067,175US$5.4m2.08%no data
0.72%
Schroder Investment Management Limited
1,040,530US$5.3m0%no data
0.71%
Susquehanna International Group, LLP, Asset Management Arm
1,032,604US$5.3m69.9%0.01%
0.61%
Balyasny Asset Management L.P.
887,014US$4.5m237%0.01%
0.5%
Kyoung Huh Sae
722,740US$3.7m0%no data
0.47%
Group One Trading LP, Asset Management Arm
678,840US$3.5m16.2%0.11%
0.45%
Woodline Partners LP
645,194US$3.3m29%0.04%
0.42%
Eun Huh Seoung
614,333US$3.1m-1.85%no data
0.4%
Jane Street Group, LLC, Asset Management Arm
582,487US$3.0m94.5%no data
0.4%
Citadel Advisors LLC
578,665US$2.9m-9.29%no data
0.38%
Tang Capital Management, LLC
550,000US$2.8m-26.7%0.32%
0.3%
Charles Schwab Investment Management, Inc.
438,191US$2.2m0%no data
0.29%
UBS Asset Management AG
413,636US$2.1m21.7%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.